RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
A One Precursor One siRNA Model for Pol IV-Dependent siRNA Biogenesis.
[EN] RNA-directed DNA methylation in Arabidopsis thaliana is driven by the plant-specific RNA Polymerase IV (Pol IV). It has been assumed that a Pol IV transcript can give rise to multiple 24-nt small interfering RNAs (siRNAs) that target DNA methylation. Here, we demonstrate that Pol IV-dependent RNAs (P4RNAs) from wild-type Arabidopsis are surprisingly short in length (30 to 40 nt) and mirror 24-nt siRNAs in distribution, abundance, strand bias, and 50-adenine preference. P4RNAs exhibit transcription start sites similar to Pol II products and are featured with 50-monophosphates and 30-misincorporated nucleotides. The 3'-misincorporation preferentially occurs at methylated cytosines on the template DNA strand, suggesting a co-transcriptional feedback to siRNA biogenesis by DNA methylation to reinforce silencing locally. These results highlight an unusual mechanism of Pol IV transcription and suggest a "one precursor, one siRNA'' model for the biogenesis of 24-nt siRNAs in Arabidopsis., We thank members of the Jacobsen lab for insightful discussions. We thank Molly Megraw for suggestions on TSS analysis and Mahnaz Akhavan for technical assistance. Wethank Dr. Jeffrey A. Long and Jared Sewell for their advice and guidance in performing ChIP-seq experiments and preparing genomic libraries. J.Z. thanks Dr. Chomdao Chommy and Seksan Sapsubbsakul for encouragement. High-throughput sequencing was performed at the UCLA BSCRC BioSequencing Core Facility. This work was supported by NIH grant GM60398 to S.E.J and NSF award 1051576 to B.C.M. S.B. is supported by a postdoctoral fellowship of the Swiss National Science Foundation. J.G-B is a Human Frontiers Science Program fellow (LT000425/2012-L). J.Z. is a Life Science Research Foundation postdoctoral fellow, sponsored by the Gordon and Betty Moore Foundation. S.E.J. is an Investigator of the Howard Hughes Medical Institute.